Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy.

Chern-Horng LeeChien-Heng ShenCho-Li YenTzung-Hai Yen Sen-Yung Hsieh

Published in: Journal of personalized medicine (2023)

Factors contributing to persistent hepatitis activity and advanced fibrosis precipitate tumor recurrence. Active intervention to discontinue liver injury or hepatitis could reduce HCC recurrence.

Keyphrases

liver injury
drug induced
randomized controlled trial
stem cells
rectal cancer
cell therapy
bone marrow
prognostic factors
liver fibrosis